Zomedica Corp. (NASDAQ:ZOM) | WebDisclosure

Basculer en Français

10069	Companies
205861	Keywords
136122	Articles
109154	Press releases

Home
Companies
Zomedica Corp.

PRESS RELEASE

published on 04/01/2024 at 22:05, 1 year 11 months ago

Zomedica Reports Record Revenue of $7.3 Million for the Fourth Quarter and $25.2 Million for the Full Year 2023, Reflecting 33% Annual Growth; 69% Gross Margin and $100.5 Million in Liquidity
Zomedica Corp. reports consolidated financial results for Q4 and full year 2023, showing significant revenue growth and progress. CEO Larry Heaton highlights momentum and strategic acquisitions for future growth

Financial Results Revenue Growth Acquisitions 2023 Zomedica Corp.
BRIEF

published on 03/20/2024 at 11:35, 2 years ago

Zomedica Announces Q4 and Full Year 2023 Financial Results Conference

Financial Results Conference Call 2023 Performance Zomedica Veterinary Health
BRIEF

published on 03/20/2024 at 11:35, 2 years ago

Zomedica annonce la conférence sur les résultats financiers du quatrième trimestre et de l'exercice 2023

Résultats Financiers Zomedica Conférence Téléphonique Santé Vétérinaire Performances 2023
PRESS RELEASE

published on 03/20/2024 at 11:30, 2 years ago

Zomedica to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Monday, April 1, 2024, at 4:30 p.m. ET
Zomedica Corp. (NYSE American: ZOM) to host conference call on April 1, 2024, discussing operational and financial highlights for Q4 and full year 2023. Company specializes in veterinary health products for companion animals

Financial Results Conference Call Companion Animals Zomedica Corp. Veterinary Health
BRIEF

published on 03/14/2024 at 11:35, 2 years ago

Zomedica's TRUFORMA Demonstrates Superior Accuracy in Feline Hyperthyroidism Diagnosis Over CLIA Platforms

Zomedica TRUFORMA Hyperthyroidism Veterinary Research Diagnostic Technology
BRIEF

published on 03/14/2024 at 11:35, 2 years ago

TRUFORMA de Zomedica démontre une précision supérieure dans le diagnostic de l'hyperthyroïdie féline par rapport aux plateformes CLIA

Zomedica TRUFORMA Hyperthyroïdie Recherche Vétérinaire Technologie Diagnostique
PRESS RELEASE

published on 03/14/2024 at 11:30, 2 years ago

Zomedica Announces Publication of Research Concluding TRUFORMA(R) Platform is More Accurate Diagnostic Test for Feline Hyperthyroidism than Chemiluminescent Immunoassay (CLIA) Platform
Zomedica Corp. announced the publication of a peer-reviewed research study comparing its TRUFORMA BAW diagnostic platform to CLIA platforms for feline hyperthyroidism diagnosis, showing superior accuracy and potential for early detection

Zomedica Corp. TRUFORMA BAW Diagnostic Platform Feline Hyperthyroidism Peer-reviewed Research Study
BRIEF

published on 03/13/2024 at 21:50, 2 years ago

Zomedica Provides NYSE American Listing Update

Reverse Stock Split Compliance Zomedica Share Price NYSE American
BRIEF

published on 03/13/2024 at 21:50, 2 years ago

Zomedica fournit une mise à jour de la cotation américaine au NYSE

Zomedica Conformité Cours De L'action NYSE Américain Regroupement D'actions
PRESS RELEASE

published on 03/13/2024 at 21:45, 2 years ago

Zomedica Provides NYSE American Listing Update
Zomedica Corp. announces ongoing dialogue with NYSE American regarding compliance with listing standards. Shares to remain listed as Company explores options

Compliance Zomedica Corp. Share Price NYSE American Listing Standards

Accesswire

Published on 03/24/2026 at 00:55, 2 hours ago

BTU Closes Oversubscribed Financing
Published on 03/23/2026 at 22:40, 4 hours 15 minutes ago

Troubadour Announces Withdrawal of Non-Brokered Private Placements
Published on 03/23/2026 at 22:30, 4 hours 25 minutes ago

Gregory J. Leia Sells Shares in Waskahigan Oil & Gas Corp
Published on 03/23/2026 at 22:00, 4 hours 55 minutes ago

Hillcrest Participates in APEC 2026 and Announces Shares for Debt Offering
Published on 03/23/2026 at 21:18, 5 hours 37 minutes ago

Amdocs Announces Appointment of Shimie Hortig to the Board of Directors Upon Shuky Sheffer's Retirement as Director and Chief Executive Officer

View all ACCESSWIRE

EQS Group

Published on 03/24/2026 at 02:00, 55 minutes ago

Discover a season of arts and sports mega events in Hong Kong
Published on 03/24/2026 at 00:55, 2 hours ago

mymediset Introduces Agentic AI for MedTech Supply Chains at LogiMed 2026
Published on 03/24/2026 at 00:09, 2 hours 45 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Appendix 3C - change of buy back details
Published on 03/23/2026 at 22:05, 4 hours 50 minutes ago

DeFi Technologies Provides Update on Timing of Annual Filings
Published on 03/23/2026 at 21:05, 5 hours 50 minutes ago

Abivax annonce ses résultats financiers pour l’exercice 2025 et fait le point sur l’avancement de ses activités

Les Echos

Published on 03/23/2026 at 19:08, 7 hours 47 minutes ago

Reporting on share buyback transactions carried out between March 16 and March 20, 2026
Published on 03/23/2026 at 19:08, 7 hours 47 minutes ago

Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 16 et le 20 mars 2026
Published on 03/23/2026 at 18:37, 8 hours 18 minutes ago

ALTAREA : Déclaration d’opérations sur actions propres
Published on 03/23/2026 at 17:45, 9 hours 10 minutes ago

ENGIE will build, own and operate its largest onshore wind farm worldwide in Egypt
Published on 03/23/2026 at 17:45, 9 hours 10 minutes ago

En Égypte, ENGIE va construire et exploiter son plus grand parc éolien terrestre au monde

View all LES ECHOS COMFI WIRE